Multiple myeloma is the second most common blood cancer in adults. World-renowned myeloma researcher, Dr. Ola Landgren, is bringing his expertise directly to patients as the new Chief of Sylvester’s myeloma program. He explains how innovative new therapies are prolonging the lives of patients who are thriving like never before. Inas Elattar is one of those patients.